IO Biotech IOBTQ Income Statement (2020-2025)

OTC IOBTQ
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT
Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Shares Outstanding (Entity) (Quarter)
0.18M0.18M0.18M0.18M4.34M28.82M28.82M28.82M28.82M28.82M28.82M50.17M43.54M65.88M65.88M65.88M65.88M65.88M65.88M69.69M
Operating items
Research & Development (Quarter)
2.21M2.85M6.74M4.13M16.44M10.31M12.23M10.02M14.43M11.90M16.50M17.66M21.77M14.31M15.85M20.18M21.15M16.38M16.65M13.74M
Selling, General & Administrative (Quarter)
0.33M0.96M2.25M2.91M4.96M6.70M5.93M5.84M5.96M6.02M5.35M5.83M6.41M5.89M5.68M6.33M5.80M6.21M6.52M5.61M
Other Operating Expenses (Quarter)
-21.53M-26.50M-22.92M-18.47M
Operating Expenses (Quarter)
2.54M3.81M8.98M7.04M21.39M17.01M18.16M15.87M20.39M17.92M21.85M23.48M28.18M20.20M26.94M22.58M0.25M0.89M
Operating Income (Quarter)
-2.54M-3.81M-8.98M-7.04M-21.39M-17.01M-18.16M-15.87M-20.39M-17.92M-21.85M-23.48M-28.18M-20.20M-21.53M-26.50M-26.94M-22.58M-23.17M-19.36M
EBIT (Quarter)
-2.54M-3.81M-8.98M-7.04M-21.39M-17.01M-18.16M-15.87M-20.39M-17.92M-21.85M-23.48M-28.18M-20.20M-21.53M-26.50M-26.94M-22.58M-23.17M-19.36M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.16M0.46M0.78M1.03M1.20M1.71M1.95M1.62M1.31M1.07M0.72M0.41M0.28M0.26M
Other Non Operating Income (Quarter)
0.02M0.14M0.15M0.02M0.01M-0.02M-0.29M-0.09M0.52M0.26M0.01M-0.34M0.41M-0.46M-0.09M1.63M-4.67M-0.10M-0.37M0.10M
Non Operating Income (Quarter)
-0.01M0.07M-29.38M2.58M0.15M-0.13M-0.23M0.29M1.30M1.29M1.21M1.37M2.35M1.16M1.22M2.70M-3.94M0.31M-2.93M9.31M
Net income details
EBT (Quarter)
-2.55M-3.75M-38.36M-4.46M46.78M-17.14M-18.39M-15.57M-19.08M-16.64M-20.65M-22.12M-25.83M-19.04M-20.31M-23.81M-30.89M-22.27M-26.10M-10.04M
Tax Provisions (Quarter)
0.15M0.07M0.10M0.12M0.90M0.40M0.50M-0.44M0.35M0.40M0.37M0.20M0.44M0.15M0.10M-1.66M
Profit After Tax (Quarter)
-2.51M-3.75M-38.36M-4.46M-21.31M-17.20M-18.50M-15.69M-20.11M-17.04M-21.18M-21.68M-26.18M-19.46M-20.69M-24.02M-31.34M-22.42M-26.22M-8.38M
Income from Continuing Operations (Quarter)
-2.55M-3.75M-38.36M-4.46M46.62M-17.20M-18.50M-15.69M-19.98M-17.04M-21.15M-21.68M-26.18M-19.44M-20.69M-24.01M-31.33M-22.42M-26.20M-8.38M
Consolidated Net Income (Quarter)
-2.55M-3.75M-38.36M-4.46M46.62M-17.20M-18.50M-15.69M-19.98M-17.04M-21.15M-21.68M-26.18M-19.44M-20.69M-24.01M-31.33M-22.42M-26.20M-8.38M
Income towards Parent Company (Quarter)
-2.55M-3.75M-38.36M-4.46M46.62M-17.20M-18.50M-15.69M-19.98M-17.04M-21.15M-21.68M-26.18M-19.44M-20.69M-24.01M-31.33M-22.42M-26.20M-8.38M
Preferred Dividend Payments (Quarter)
0.87M1.84M2.09M2.07M1.10M
Net Income towards Common Stockholders (Quarter)
-3.42M-5.59M-40.45M-6.54M-22.41M-17.20M-18.50M-15.69M-20.07M-17.04M-21.18M-21.68M-26.18M-19.46M-20.69M-24.02M-31.33M-22.42M-26.22M-8.38M
Additional items
EPS (Basic) (Quarter)
-19.32-31.53-228.29-36.88-5.17-0.60-0.64-0.54-0.70-0.59-0.73-0.43-0.60-0.30-0.31-0.36-0.48-0.34-0.40-0.13
EPS (Diluted) (Quarter)
-228.29-36.88-5.17-0.60-0.64-0.54-0.70-0.59-0.73-0.43-0.60-0.30-0.31-0.36-0.48-0.34-0.40-0.13
Shares Outstanding (Quarter)
0.18M0.18M0.18M0.18M4.34M28.82M28.82M28.82M28.82M28.82M28.82M50.17M43.54M65.88M65.88M65.88M65.88M65.88M65.88M66.94M
Shares Outstanding (Diluted) (Quarter)
0.18M0.18M4.34M28.82M28.82M28.82M28.82M28.82M28.82M50.17M43.54M65.88M65.88M65.88M65.88M65.88M65.88M66.94M
EBITDA (Quarter)
-2.54M-3.81M-8.98M-7.04M-21.39M-17.01M-18.16M-15.87M-20.39M-17.92M-21.85M-23.48M-28.18M-20.20M-21.53M-26.50M-26.94M-22.58M-23.17M-19.36M
Interest Expenses (Quarter)
0.01M0.07M0.07M0.07M0.15M0.12M2.73M0.12M-0.00M0.17M3.15M2.93M0.19M0.19M0.19M2.21M0.20M0.21M5.29M10.43M
Tax Rate (Quarter)
0.33-0.39-0.57-0.74-4.70-2.40-2.421.98-1.37-2.10-1.84-0.84-1.43-0.66-0.3816.57